Denali Therapeutics Inc. (DNLI) gained 8.23% or 1.14 to $15.0. It is nearly 503262 shares traded, which is 123.42% compare to the average total volume 407765. The market cap of DNLI is $1.42 billion. The year to date change is -5.85%. The 52 week price range is from $12.32 to $25.79. Price of DNLI have changed 11.24% during last week. It have changed -10.81% over last month, -25.60% over last 3 months, -34.56% over last 6 months and -35.38% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DNLI is 16.46. It is 9.73% above current price. The 200-day Moving Averages for DNLI is 18.74. It is 24.93% above current price. The 52-week High is 25.79. It is 71.93% from the current price. The 52-week Low is 12.32. It is -17.87% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of DNLI is 15.47 on 2018-07-13. Short % to float is 7.14%. There are some statistics of DNLI. It is has market cap $1.42 billion. The share outstanding is 94.44 million. The average volume is 407765. The percent of top 15 Institution holding is 87.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DNLI is -16.80%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DNLI is -14.75%.